Buy Google 3/1/2021Google is moving in a short-term upward trend.
It tests EMA 13 and 34
So you can buy
1845.5 target and stop losses 1678.7
Stockideas
I am on the TeamAtlassian has been a great performer over the past year and that trend might continue into 2021. Going long with a stop at 219 looking all time highs is a decent risk/reward opportunity. Earnings could be a catalyst as well.
FTAC Olympus stock surges after Payoneer merger talks reportedPayoneer Inc., an online payments specialist, is in talks to go public through a merger with FTAC Olympus Acquisition Corp., a blank-check firm, according to people with knowledge of the matter.
The special purpose acquisition company has begun talks to raise new equity to support a transaction that’s slated to value the combined entity at more than $2.5 billion, said one of the people, who asked to not be identified because the matter isn’t public. As a deal isn’t finalized, it’s possible terms change or talks fall apart.
Representatives for New York-based Payoneer and FTAC declined to comment.
Founded in 2005, Payoneer -- which has said it’s profitable -- is backed by investors including Wellington Management Co., TCV, Greylock Partners, Ping An and Viola Ventures. The company, founded in Israel by Yuval Tal and now led by Chief Executive Officer Scott Galit, operates in more than 200 countries and territories. It provides services including cross-border payments for customers including Airbnb Inc., Amazon.com Inc., Google and Walmart Inc. its website shows.
FTAC, led by Chairman Betsy Cohen and Chief Executive Officer Ryan Gilbert, raised roughly $755 million in an August initial public offering for the purpose of acquiring or merging with a technology or financial services technology-focused company.
Read More: SoFi Plans for More Mergers After Going Public Through SPAC
Cohen is also chairman of blank-check firms FinTech Acquisition Corp. IV, which last month agreed to combine with Perella Weinberg Partners, and FinTech Acquisition Corp. V. She’s also chairman of FTAC Athena Acquisition Corp. which this week filed paperwork ahead of a targeted $220 million IPO and was the chairman of FinTech Acquisition Corp. III when it merged with payments company Paya Holdings Inc.
www.reddit.com
This trade was sickTDOC has gone from a range reversal trade to a potential breakout. I am very happy holding for now but I am watching how price reacts to the top end of the range. As long as price can hold above 220 the trend is still positive even if there is a little profit taking to come.
Going for the WYNN As wynn retests the range high support zone, I am looking for a further breakout toward the 120 area. As long as 100 holds the trend still appears to be bullish. Obviously the digitization of gaming is a huge secular shift but it doesn't mean that the incumbents like wynn wont prosper in the new environment. And I cant speak for anyone else but a weekend at a wynn resort in a post vaccine world sounds like a good idea. Same goes for LVS for that matter.
Tilman Fertitta Is in Talks to List Casino, Dining firm Via FSTTilman Fertitta Is in Talks to List Casino, Dining Assets Via SPAC
Texas billionaire and Houston Rockets owner Tilman Fertitta is in talks to take his casino and restaurant empire public through a merger with blank-check firm Fast Acquisition Corp., according to people with knowledge of the matter.
The special purpose acquisition company is in talks to raise more than $1 billion in new equity to support a transaction, said the people, who asked to not be identified because the matter isn’t public. The deal could value the combined entity at up to $7 billion including debt, one of the people added.
The new company, which Fertitta would still control, is set to include casinos and restaurants under the Golden Nugget and Landry’s umbrellas, they said. If talks are successful, a deal could be announced n the coming weeks. Terms may change and discussions could still fall apart.
Representatives for Golden Nugget and Fast Acquisition declined to comment.
finance.yahoo.com
Sorrento could surge 275% in 2021, Here is why...H.C. Wainwright analyst Ram Selvaraju rates SRNE a Buy along with a $30 price target, which implies a 275% upside from current levels.
Factors behind the optimistic outlook:
1. Sorrento has a stake in two cell-based immunotherapy companies that could “drive value in Sorrento shares over the coming months.”
2. the analyst highlights Sorrento’s “burgeoning portfolio of assets spanning three distinct therapeutic areas (non-opioid pain management, oncology and COVID-19).”.
3. two rapid COVID 19 detection tests; COVI-STIX, for which the company filed for Emergency Use Authorization (EUA) in the U.S. in December, and COVI-TRACE, which Selvaraju claims could come in handy at any mass gathering event.
“We believe that the incentive to facilitate the large-scale and indeed ubiquitous deployment of the COVI-TRACE test is extremely high and governments worldwide may seek to implement this in their respective regions,” the 5-star analyst opined.
4. Other Covid-19 candidates include COVIGUARD - a SARS-CoV-2 neutralizing antibody, COVI-AMG - an affinity-matured version of the COVIGUARD neutralizing antibody, a neutralizing antibody cocktail named COVI-SHIELD and COVIDTRAP, an ACE2 receptor decoy, intended to imitate the mammalian ACE2 receptor that acts as the primary portal for the SARS-CoV-2 virus to penetrate human cells.
finance.yahoo.com
Owl Rock, Dyal Capital to go public via SPAC mergerOwl Rock and Dyal to combine to form Blue Owl, a differentiated alternative asset manager with industry leading Direct Lending and GP Capital Solutions businesses
Combined firm to manage over $45.0 billion in assets
Blue Owl to become publicly listed through a business combination with Altimar, a SPAC sponsored by an affiliate of HPS Investment Partners (NYSE:ATAC)
Blue Owl is expected to be listed on the NYSE under the ticker symbol "OWL" following the expected close of the transaction in the first half of 2021.
Transaction expected to provide approximately $1.8 billion in gross proceeds, comprised of Altimar’s $275 million of cash held in trust (assuming no redemptions) and a $1.5 billion fully committed, oversubscribed, common stock PIPE at $10.00 per share, including investments from ICONIQ Capital, CH Investment Partners, Koch Companies Defined Benefit Master Trust, the Federated Hermes Kaufmann Funds, and Liberty Mutual Investments
The founders and senior managers of Blue Owl will retain their equity stakes through the combined entity’s transition into a publicly listed company, promoting continued alignment.
The combined entity is expected to have a post-transaction market capitalization of approximately $12.5 billion.
finance.yahoo.com
Achronix to List on Nasdaq Through Merger With ACE ConvergenceAchronix is the only independent supplier of high-performance FPGAs and eFPGA IP based data acceleration solutions used in high-growth applications including AI, cloud computing, 5G, networking and automotive driver assistance
Highly differentiated financial profile with estimated 2020 revenues of approximately $105 million, 79% gross margins and 35% operating margins with migration to next-generation products driving an estimated revenue CAGR of 20% to 25% from 2020 to 2025
Business combination with ACE Convergence Acquisition Corp. (Nasdaq: ACEV) positions Achronix to capitalize on non-cancellable backlog in excess of $160 million and over $1.1 billion in identified pipeline opportunities driven by Speedster® and Speedcore™ products
Approximately $2.1 billion estimated post-transaction equity value based on current assumptions with up to $330 million in gross cash proceeds to the company, assuming minimal redemptions
Oversubscribed $150 million fully committed common stock concurrent PIPE financing at $10.00 per share anchored by ACE Equity Partners LLC, funds and accounts managed by BlackRock and Hedosophia; and with participation from other institutional investors
Achronix expected to be listed on Nasdaq under the ticker symbol "ACHX" following an anticipated transaction close by the end of the first half of 2021
Customer validation of Achronix’s products is substantiated by nearly $240 million in orders received in 2020 . Achronix’s new Speedster7t and Speedcore products, built on leading-edge process technology, have contributed to a design pipeline value in excess of $1.1 billion and are expected to drive Achronix’s future growth.
"The next era of growth and opportunity is in the trillions of connected devices providing compute-intensive intelligence, all fueled by network connectivity and 5G,"
finance.yahoo.com
Parabolic watchThe stocks run has been incredible after the range breakout. I don't have a fundamentally bearish view of the company but a pause seems imminent especially if the rate of change has peaked.
Setup for this weekAMD has broken down back into the broader range and is showing relative weakness. If we can get above Fridays close we could see a move back toward the high end of the range and a breakout but if the near term resistance holds we will see a move down. Earnings will definitely be a factor but are still a couple of weeks out.
Trade Update #stocksThe Chart: Price has fully reversed from the bottom of the large range (rectangle) and has now broken out of the top end of the range. Despite todays rough down day I am comfortable with my position as long as price can hold above the 59 area.
The Narrative: Banks are taking a bit hit on earnings but the quarterly results we not as bad as the price drop may seem. Given the run most including Citigroup have had, taking some profits into the quarterly results was some what expected. The recent move in interest rates, reopenings, and overall global growth should all be tailwinds for the sector. Unless there is a double dip recession, I think the banks have more room to run especially if we hold the 59 area for Citi specifically.
Full Commercial Launch of Tigereye(TM) Image-Guided CTO CrossingAvinger Initiates Full Commercial Launch of Tigereye(TM) Image-Guided CTO Crossing Catheter
With the initiation of full commercial launch, current and prospective accounts throughout the US and Germany are now able to order the Tigereye device.
During the fourth quarter of 2020, Avinger conducted a limited launch at 12 clinical centers in the U.S. and Germany. Approximately 50 CTO cases were successfully performed, showcasing Tigereye's advanced clinical capabilities and excellent product reliability in a variety of lesion types and settings.
The limited launch program demonstrated Tigereye's strong clinical results and efficiency across a wide range of PAD cases
"We believe full commercial availability of the Tigereye device will be an important contributor to expanding our revenue growth opportunities in 2021, both in terms of attracting new Avinger user sites and supporting higher utilization per site,"
finance.yahoo.com
Reversal back into the range? #stocksThe Chart: If price can break this down trendline I am looking for the stock to move higher back into the range. Looking for the opposite of the downward reversal back on December 8.
The Narrative: Despite the reopening online sales will continue to grow. Although Amazon is increasing becoming a competitor, the shipping market is largely a duopoly and as the economy improves they should have pricing power.
CHRA Awarded Large-Scale, 12-Year Ash Marketing ContractCharah Solutions Awarded Large-Scale, 12-Year Ash Marketing Contract by Dominion Energy for Beneficial Use of 8.1 Million Tons of Reclaimed Ponded Coal Ash
For the beneficiation and utilization of up to 8.1 million tons of reclaimed ponded coal ash at its Chesterfield Power Station in Chester, VA. Dominion Energy is headquartered in Richmond, VA.
As part of the agreement, Charah Solutions will install processing and transportation infrastructure in 2021 to facilitate rail transportation of the ash from Chesterfield Power Station to cement kiln feed markets.
finance.yahoo.com
AVAV to Acquire Arcturus UAV, Expanding Product PortfolioAeroVironment to Acquire Arcturus UAV, Expanding Product Portfolio and Reach into Group 2 and 3 Unmanned Aircraft Systems Segments
Total transaction value of $405 million in cash and stock, including $355 million in cash and $50 million in AeroVironment stock.
Arcturus UAV has a demonstrated track record of solid performance, with topline growth exceeding 20 percent for each of its last two fiscal years.
Arcturus UAV’s complementary capabilities provide program diversification, increase key customer penetration and enhance shareholder value
Arcturus UAV is well positioned for ongoing United States Special Operations Command (USSOCOM) Mid-Endurance UAS (MEUAS) task orders, United States Army Future Tactical UAS (FTUAS) program delivery orders and international contracts
Expected to be immediately accretive to revenue growth, adjusted EBITDA margin and non-GAAP diluted EPS, excluding intangible assets, amortization expense and deal and integration costs, and accretive to GAAP diluted EPS by fiscal year 2022
Group 2 and 3 UAS and services, collectively, potentially represent more than one billion dollars in annual contract value, according to an independent forecast.
The Arcturus UAV team has produced strong growth in recent years and has secured strategically important wins in the MEUAS and FTUAS programs, positioning Arcturus as a leader for next-generation program requirements
In connection with the acquisition, AeroVironment has received commitments for a $200 million Term Loan Facility and $100 million revolver (undrawn at close) with Bank of America, N.A. acting as Administrative Agent, and with BofA Securities, Inc., JPMorgan Chase Bank, N.A. and U.S. Bank National Association acting as arrangers. AeroVironment will fund approximately $155 million of the acquisition from cash on hand.
finance.yahoo.com
TOASO BOĞA TRENDİ BAŞLIYORÖnemli bir direnç noktası kırıldıktan sonra düzeltme yapan bu kağıt önemli bir boğa trendinin başlangıcında.
When will it be time to pause the GME? #stocksThis recent move in GME has be extraordinary to say the least but what matters now is when to temporarily put the controller down and take a break. On a short term basis I am watching the regression channel from the past two days. While we remain in the channel the game is still on but below the channel means its time to rest your fingers
GameStop Soars With Activist Ryan Cohen Gaining Board SeatsGameStop Soars With Activist Ryan Cohen Gaining Board Seats
GameStop Corp. jumped after activist investor Ryan Cohen stepped up his transformation efforts at the struggling video-game retailer, gaining a seat on the company’s board along with two allies.
Cohen’s RC Ventures -- GameStop’s second-largest shareholder, with a 13% stake -- has been pressing the Grapevine, Texas-based chain to undertake a strategic review to cut more costs. Cohen, the entrepreneur who helped build up the Chewy pet-supply site, also wants GameStop to increase the variety of products and services it offers online.
“We are excited to bring our customer-obsessed mindset and technology experience to GameStop and its strategic assets,” Cohen said in a statement Monday.
The stock rocketed up 210% last year on hopes that it would benefit from the release of new video-game consoles. GameStop lost some ground in early December after reporting third-quarter sales that missed estimates and announcing plans to sell more stock, but it rebounded toward the year’s end.
Along with Cohen, Alan Attal and Jim Grube are joining the GameStop board. Both men worked with Cohen at Chewy.
That news seemed to overshadowed a disappointing holiday sales release from GameStop, GameStop reported a 4.8% year-over-year increase in comparable-store sales for the nine-week holiday period ended Jan. 2. Coronavirus-related losses of store traffic knocked a high-single-digit to low-double-digit percentage off those sales, the company said, and net sales dropped 3.1% to $1.77 billion.
finance.yahoo.com
GameStop CEO George Sherman said in the news release that “together, we have reached an outcome that is in the best interest of all stockholders and can enable GameStop to accelerate efforts to deliver enhanced value for the company.”
Excitement that Cohen can help turn things around was compounded by the stock’s high short interest, estimated at about 58% of shares available for trading, according to data from S3 Partners. That’s left the stock primed for a short squeeze. But the rise of digital game downloads amid declining earnings necessitate a bold new strategy.
www.barrons.com
This NCNA Penny Stock Could Surge Over 300%, Say AnalystThis NCNA Penny Stock Could Surge Over 300%, Say Analyst
NuCana uses a phosphoramidate chemistry technology called ProTide to create a class of drugs that will surmount the limitations of the existing nucleotide analogs behind many chemotherapy drugs. NuCana’s ProTides have already been used in Gilead’s antiviral drug Sovaldi.
In May of last year, NuCana announced the restart of its Phase III trial on Acelarin, the drug candidate furthest along the company’s pipeline, as a treatment for biliary tract cancers. The study encompasses over 800 patients in 6 countries and is currently ongoing. In November, the company published data described as ‘encouraging’ from the Phase Ib study of the same drug.
While Acelarin is the flagship drug in the pipeline, NuCana has two other prospects under development. NUC-3373 is in Phase I trial as a treatment for solid tumors and colorectal cancers, and NUC-7738 is a second pathway under investigation for applications to advanced solid tumors. Of these three, the colorectal study is the farthest advanced.
5-star analyst Robyn Karnauskas sees the pipeline as key to NuCana’s investor potential.
“We believe investors have overlooked the fact that NCNA is a platform Company that we believe is validated, as defined by the production of clinical products. We like that it has brought 3 products to the clinic, including one novel drug and two improved cornerstone chemos. The data suggest to us that the platform works and can produce better chemos While investors are mostly focused on Acelarin, we believe investors should also focus on NUC-3373, another core to our platform-based thesis that has data expected in 1H2021,” Karnauskas noted.
To this end, Karnauskas puts a $22 price target on NCNA, suggesting the stock has room for 384% growth ahead of it, along with a Buy rating.
finance.yahoo.com
Penny stock Zomedica jumps 250% Here is why.....Penny stock Zomedica jumps 250% after someone paid Netflix star Carole Baskin $299 for a mention
Little known Michigan-based animal health and veterinarian penny stock Zomedica surged nearly 250% since earning a mention from Netflix’s “Tiger King” star Carole Baskin last week. In a video re-posted to YouTube, Baskin delivers a glowing review for the company, saying "I don't know if you guys have heard about Zomedica, but they help our veterinarians and our furry friends” and that she is “definitely invested in finding out more” about the company.
But Yahoo Finance has confirmed that what appeared to be an endorsement from Baskin was nothing more than the result of a request from someone on Cameo, a platform where users can pay for video messages.
“It was a Cameo they paid for,” Baskin told Yahoo Finance. “I don't hold any stock in the company and don't make stock recommendations.”
It’s also possible the request could have come from an outside investor looking to spark an increase in the share price that sat at just $0.40 last week.
The Ann Arbor, Michigan-based company, which went public in 2016, has yet to achieve any revenue, according to financial statements
The penny stock was also among the most actively traded by volume on popular retail investor platform Robinhood, according to analytics firm Breakout Point.
Baskin says she wasn’t able to recall who ordered the message that requested she seemingly endorse the upcoming launch of Zomedica’s testing platform for disorders in dogs and cats . In Baskin’s video, she echoes that “they think it’s going to be a really big seller.”
Baskin expressed her doubts that she alone could have influenced the excitement.
finance.yahoo.com
USWS and RRC Finalize Extension of Electric Frac Contract U.S. Well Services and Range Resources Corp. Finalize Extension of Electric Frac Contract
finalized an extension of its contract to provide electric hydraulic fracturing services-revolutionary Clean Fleet® electric hydraulic fracturing solution for Range Resources Corp. (NYSE: RRC) in the Appalachian Basin.
finance.yahoo.com stock
